1398张门诊高龄患者抗高血压药处方用药分析

目的:探讨门诊高龄患者抗高血压药处方用药情况,为合理用药提供参考。方法:选取上海市闵行区古美社区卫生服务中心(以下简称"我院")2017年1—6月门诊高龄患者(年龄≥85岁)抗高血压药处方1 398张,采用用药频度(defined daily dose system,DDDs)和药物利用指数(drug utilization index,DUI)分析法,对高龄患者抗高血压药使用情况进行统计分析。结果:1 398例高龄患者中,85-90岁患者所占比例最大(79.40%,1 110/1 398);女性患者所占比例(62.80%,878/1 398)高于男性(37.20%,520/1 398)。DD...

Full description

Saved in:
Bibliographic Details
Published in中国医院用药评价与分析 Vol. 17; no. 10; pp. 1391 - 1394
Main Author 金蕾;杨耀芳;魏新萍;储继志;陈家仪
Format Journal Article
LanguageChinese
Published 上海市闵行区卫生和计划生育委员会,上海 201199 2017
上海市闵行区古美社区卫生服务中心,上海,201102%上海市闵行区古美社区卫生服务中心,上海 201102
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:目的:探讨门诊高龄患者抗高血压药处方用药情况,为合理用药提供参考。方法:选取上海市闵行区古美社区卫生服务中心(以下简称"我院")2017年1—6月门诊高龄患者(年龄≥85岁)抗高血压药处方1 398张,采用用药频度(defined daily dose system,DDDs)和药物利用指数(drug utilization index,DUI)分析法,对高龄患者抗高血压药使用情况进行统计分析。结果:1 398例高龄患者中,85-90岁患者所占比例最大(79.40%,1 110/1 398);女性患者所占比例(62.80%,878/1 398)高于男性(37.20%,520/1 398)。DDDs排序居前3位的抗高血压药种类分别为钙通道阻滞剂、血管紧张素Ⅱ受体阻断剂和β受体阻断剂;DDDs排序居前3位的药品依次为苯磺酸左旋氨氯地平片、缬沙坦胶囊(国产药)和酒石酸美托洛尔片(非国产药)。结论:我院门诊高龄患者抗高血压药的使用基本合理,但也存在一些问题。临床不仅应根据高龄患者的特点选择合适的抗高血压药种类,而且需要考虑药物效能,选择正确的剂量。
Bibliography:OBJECTIVE:To probe into the application of antihypertensive drugs for elderly patients in 1398 outpatient prescriptions , so as to provide reference for the rational drug application .METHODS:1398 outpatient prescriptions from elderly patients ( aged ≥85 years old ) admitted from Jan .to Jun.2017 in Shanghai Minhang District Gumei Community Health Center ( hereinafter referred to as "our hospital") were extracted , statistical analysis was conducted on application data of antihypertensive drugs by using defined daily dose system ( DDDs ) and drug utilization index ( DUI).RESULTS:Of the 1398 elderly patients, patients aged 85-90 years old took the lead (79.40%, 1110/1398 ) .The ratio of female patients ( 62.80%,878/1398 ) was higher than the male patients (37.20%,520/1398).The top three antihypertensive drugs ranked by DDDs were respectively calcium channel blockers , angiotensin Ⅱ receptor blockers and β-adrenoceptor blocker .The top three drugs ranked by DDDs were respectively Levamlodipine besylat
ISSN:1672-2124
DOI:10.14009/j.issn.1672-2124.2017.10.034